Résultats de la recherche - 8 results
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
assessment, we considered it as high-risk (hr) HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and ...
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
the population prevalence for other anogenital cancers is too low for population-based screening, anal cancer incidence is very high in HIV-infected men who have sex with men, warranting consideration ...
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
compare conventional and liquid-based cytology (LBC), estimate the prevalence of abnormal cervical cytology and high risk HPV (hrHPV) infection and their correlation, among screened women in Luxembourg. ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
Prevalence of hrHPV types (high-risk HPV) increased with severity of cytology. The concordance between PapilloCheck and the GP5 +/6+ LMNX Assay was excellent when assessed at the qualitative hrHPV ...
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
of Tests Reproducibility of Results Scotland specimen handling Urinalysis Vagina Abstract: OBJECTIVES: Papillomavirus Dumfries and Galloway (PaVDaG) assessed the performance of a high-risk human ...
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
Abstract: BACKGROUND: It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. If ...
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.
generated in the Validation of HPV Genotyping Tests (VALGENT) framework. Through VALGENT, we assessed the performance of the BD Onclarity HPV assay, which detects 14 high-risk (HR) types and resolves six ...
Low prevalence of previous lower limb revascularisation in patients with diabetes and acute Charcot foot: results from a case-control study.
charcot foot diabetes lower-limb revascularization Abstract: Aim: Charcot foot is a rare but devastating complication of diabetes, leading to uncontrolled inflammation and high risk of osteolysis in its ...